Volufiline has gone from a somewhat niche cosmetic active to an ingredient that beauty founders, formulators and product managers are asking about much more frequently.
And it’s not TikTok or some other latest social media craze that’s driving that interest. In September 2026, Croda Beauty called Volufiline™ a heritage active that is seeing a resurgence in interest as consumers become more aware of the appearance of facial fullness and age-related loss of volume.
But for brands, that’s only the start of finding an interesting ingredient.
One of the most common mistakes we see in sourcing is to find a supplier that sells something called a “Volufiline serum” and assume the active material, concentration, supporting formula, documentation and manufacturing standard will be the same from one supplier to another.
They’re not.
Volufiline™ is a cosmetic ingredient, not a finished product. Its INCI is Hydrogenated Polyisobutene (and) Anemarrhenae Asphodeloides Root Extract How that material is incorporated into a serum, cream, oil or eye treatment is a function of the complete formulation.
So a serious manufacturing conversation needs to go beyond, “Do you have Volufiline?”
We would also want to know the source of the material, what percentage is actually being discussed, what the rest of the formula looks like, how the product has been tested, what packaging is suitable and what cosmetic claims can realistically be supported in the destination market.
This guide focuses on manufacturers where we could find public evidence that links a real Volufiline containing product with OEM, ODM, private label or contract manufacturing capability.
We didn't just look for cosmetic factories that say they can formulate anti-aging skincare and put this list together.
To make the shortlist we looked for two forms of public evidence.
First, there had to be evidence that the company had already made, developed or marketed a skincare product with Volufiline, not just mentioned the ingredient in a blog post.
Second, we searched for the presence of OEM, ODM, private label or contract manufacturing capability.
We also thought about how useful that experience could be to an independent beauty brand. For example, a factory with several Volufiline formats may be more relevant to a brand building a collection, while a low-MOQ manufacturer may make more sense for a founder trying to validate one hero product.
| Manufacturer | Country | Publicly Verifiable Volufiline Experience | Manufacturing Model | Best Fit |
|---|---|---|---|---|
| Xiran Skincare | China | Serum, serum oil, cream, eye cream | Private Label / OEM / ODM | Complete customized Volufiline ranges |
| Trilogy Laboratories | USA | Face oil, neck & décolleté cream | Private Label / Custom Manufacturing | Low-MOQ US launches |
| LISSE KOREA Inc. | South Korea | Genuine French Volufiline products | OEM / ODM | Professional and K-beauty skincare |
| COSMEDIQUE Co., Ltd. | South Korea | Volufiline + EGF + peptide skincare | OEM / ODM | Derma and aesthetic positioning |
| Laboratoire Orescience | France | Volufiline body volumizing formula | Private Label / OEM / Custom | Made-in-France projects |
| THE MOMENT | South Korea | B-Volume Volufiline range | OEM / ODM / OBM | Premium trend-led K-beauty |
| BORNTREE | South Korea | DR.TREE VOLU 10 range | OEM | Multi-SKU Volufiline concepts |
| Korea Awesome Skincare | South Korea | Volufiline + peptide cream | OEM / ODM / OBM | Active anti-aging skincare |
| Uniqueglobal | South Korea | 3% Volufiline serum | OEM / ODM | Small launches and serum testing |
| Pion-Tech | South Korea | Volufiline multi-active skincare | OEM / ODM | Established Korean active skincare |
Xiran Skincare is a manufacturer of private label and OEM/ODM skin care. We have developed a Volufiline product platform that includes a 3% Volufiline spherical peptide firming serum, 5% Volufiline serum oil, 5% Volufiline anti-wrinkle cream and 5% Volufiline peptide eye cream.
This gives a brand more flexibility to think about the ingredient as a whole, not as a single trending SKU.
A lightweight serum may be a good candidate for an ecommerce-led launch while a richer serum oil may help support a more nourishing mature-skin concept. Cream and eye-care formats can also help a brand extend the ingredient story into a routine rather than competing only in an increasingly crowded serum category.
We can replace the label on one stock product or work with the supporting active system, texture, skin feel, fragrance direction and packaging on OEM/ODM projects. Our broader private label manufacturing service also includes sampling, packaging sourcing, testing and commercial production.
“If a brand is looking at this route, I would decide early on whether it is really private label, semi-custom or fully customised. That decision has a far greater impact on development time, MOQ, packaging options, formula ownership and cost than the ingredient name alone.
Ideal for: brands looking for formulation flexibility or a coordinated Volufiline range rather than a ready-stock serum.
For a US-based founder who wants to test demand without having to commit to several thousand units right off the bat, Trilogy Laboratories is one of the most interesting companies in this comparison.
Today, the private label catalogue includes over 550 ready-to-brand formulations, with a minimum of 25 units/SKU to begin. Trilogy also says it makes products at its GMP ISO 22716 certified, MoCRA-compliant plant in Fort Myers, Florida.
The evidence for Volufiline is also unusually direct.
Anemarrhena asphodeloides root extract is used as Volufiline™ in the Timeless Face Oil. Volufiline is listed with other firming ingredients in the private-label-ready Neck & Décolleté Firming Cream. Both product pages show the same 25 unit private label minimum.
This makes Trilogy useful for a very different type of project than a traditional high volume contract manufacturer.
If a founder is not sure whether a Volufiline idea will really translate into repeat purchases, testing 25, 50 or 100 pieces involves far less inventory exposure than ordering 3,000–5,000 units right away.
The downside is that buyers shouldn’t confuse low-MOQ private label with low-MOQ full custom formulation. Once you change the formulation, packaging or the technical requirements then the economics can be very different.”
For aestheticians, med spas, professional practices and emerging US brands, Trilogy is however a strong competitor to compare with.
South Korea is well represented on this list and LISSE KOREA Inc. is one of the more obvious reasons why.
The official 2026 InterCHARM Korea exhibitor profile lists the company as a skincare manufacturer and contract manufacturer (OEM/ODM). The same profile describes LISSE as a cosmetics R&D company providing OEM and ODM through the Lisse Skin Science Research Institute, and specifically mentions a product line including 'French genuine Volufiline products'.
There is also a DAYLISSE Volufiline cream that is publicly listed as using the original French material which gives buyers another product level reference point.
This is helpful because one of the first questions that should be asked during a Volufiline sourcing project is authenticity.
An INCI list with Anemarrhena-related material doesn't automatically tell you which commercial active has been used, nor does it say anything about whether the supplier can provide supporting raw-material documentation.
LISSE also seems more targeted toward the professional, aesthetic and higher function skincare than the basic mass market white label products.
This makes it particularly attractive for a brand launching a clinic or premium K-beauty concept.
“Before we go any further, I would ask which existing Volufiline formulations can actually be supplied to third party brands, which projects require new ODM development and what ingredient-origin documentation is available.
COSMEDIQUE has been making this longer than many of the newer trend based suppliers entering the Volufiline market.
The company states it has been making cosmetics since 1985 and now offers OEM/ODM for skincare, makeup, and derma-cosmetics from GMP-certified facilities. The existing program is private label and OEM/ODM production of about 1,000 units for selected projects.
The Volufiline link is through the DR. JECORI skincare range.
COSMEDIQUE describes this premium anti-aging line as being formulated with a combination of ingredients including plant callus, Volufiline, EGF and peptides, while separately stating it produces OEM/ODM products for third parties.
This is why I would consider COSMEDIQUE differently than I would a one-hit-wonder supplier of a viral Volufiline serum.
The better fit may be for a brand creating a multi-active derma concept where Volufiline is part of a bigger formulation story with peptides or other premium actives.
That may be more commercially defensible than just competing on “3% vs. 5% vs. 10%.”
The biggest discussion early on here is whether you want to adapt an existing formulation platform or pay for a more original formula. These paths can differ greatly in terms of time to develop, cost, exclusivity and ownership.
If the Made in France is an important element in the positioning of your brand, Laboratoire Orescience is a serious candidate to consider.
Orescience is a French cosmetic laboratory offering white label, private label, OEM/ODM and custom formulation services in facial care, body care and other categories.
More significantly, its formula catalogue is a direct testimony to experience formulating with Volufiline.
Among its products publicly documented is a targeted volumising and firming body gel with Volufiline and other ingredients to support it. The formula is part of Orescience’s private-label body-care line and brands can use its services for development, manufacturing, packaging and labelling.
This product is not another run-of-the-mill facial dropper serum, and that’s what I find interesting about it.
The Volufiline market is now crowded with facial serums. If the formula, claims and target market compliance are done correctly, then there is more room for a brand to differentiate through body care, décolleté treatments or other targeted application.
So I find Orescience more logical for a company who cares about French manufacturing and wants real formulation development and not just buying the cheapest ready product.
THE MOMENT is on the more premium and trend-responsive side of Korean cosmetics manufacturing.
The company says it has its own research and manufacturing facilities and offers OEM/ODM services as part of a wider one-stop model for planning, manufacturing, design, marketing and distribution.
Its own DIFFER&DEEPER portfolio is also an unusually clear proof of Volufiline experience.
The B-Volume family includes the B-Volume Daily Shot and B-Volume Mix&Max Cream products. Other Volufiline eye-care concepts are currently listed with B2B. Selected products of THE MOMENT are also available in TradeKorea through production models of OEM, ODM and OBM.
This is more meaningful to a product developer than to see one generic Volufiline SKU.
It implies the company has already worked with the ingredient in a variety of formats and alongside peptide, collagen and other firming-oriented concepts.
The buyer still has to separate brand-owned formulations from those available to OEM customers. Experience shows that a manufacturer’s own branded product does not necessarily mean that the exact same formula can be rebranded or manufactured for another brand.
That is the first question I would ask THE MOMENT.
BORNTREE is famous for the diversity of its Volufiline family.
The DR.TREE VOLU 10 line has a variety of products such as cream, essence, body serum mist, eye care products and lip products.
The supplier listed by TradeKorea is BORNTREE, and many of the products in the range are shown with OEM as production method. Their eye-care product is listed with Volufiline at 50,000 ppm, while the essence and other SKUs also use Volufiline as part of the formulation concept.
This sort of range gives us something useful about practical formulation experience for buyers.
A supplier that has used an ingredient in creams, essences, body products and lip formats is not necessarily the same as a manufacturer that has used it only in an oil serum.
This is not to say that a brand should simply copy the DR.TREE range.
That does mean BORNTREE might be worth a mention if your product strategy already goes beyond a single 30 ml serum.
I would clarify one thing before development. Ownership of the formulas. Are these existing formulas available as OEM platforms, can they be modified or does a third party brand need a completely new formula?
That answer will drive both cost and differentiation.
Korea Awesome Skincare is not as large or as well-known internationally as some of the Korean contract manufacturers, but their public B2B documentation is remarkably thorough.
The company is labelled as a manufacturer in its TradeKorea listing and its anti-aging peptide cream is clearly stated to be available through OBM, ODM and OEM production methods.
The formula includes seven peptides, including Volufiline, an ingredient from Sederma France.
That makes the company relevant to brands developing Volufiline + peptide concepts and not basic commodity skincare products.
It could also be a good fit for buyers who would rather deal with a smaller Korean supplier than get into the systems and minimums of a very large contract manufacturer.
However I would be wary of using marketplace MOQ figures as the basis for a project.
MOQ needs to be confirmed separately for:
A “negotiable MOQ” on a B2B platform doesn’t tell you what a commercially finished custom launch will cost you.
If you want starting off with a serum and try out the category before developing a bigger range, Uniqueglobal is a brand worth comparing.
It makes its Bellflower Propolis Volufiline Firming Serum in South Korea and says it contains 3% Volufiline, as well as propolis, honey, adenosine and other supporting ingredients.
Uniqueglobal is a manufacturer based on TradeKorea. The product can be produced with the following available production methods: ODM, OEM.
The listing also has a very low published MOQ.
I wouldn’t necessarily read that number as the MOQ for a fully bespoke private label project.
Market minimums can be a current branded SKU, stock configuration or wholesale transaction. If you're making up your own formula, the minimums for printing packaging and making a finished retail product are totally different.
That distinction is part of what makes Uniqueglobal a useful example of something beauty founders should learn early:
wholesale, private label and custom OEM are not the same thing.
Ask the supplier to price each option individually.
I would replace the weaker sourcing lead in the original version of this list with Pion-Tech, as the public evidence connecting Volufiline to actual manufacturing capability is clearer.
Pion-Tech is a South Korean manufacturer established in 2001, TradeKorea said. Its Volume Tox Signature Combo includes Volufiline, along with other active-skincare ingredients, such as peptides, ceramide, hyaluronic acid and more.
Crucially for this article, the same listing clearly states that the production method is ODM and OEM.
That gives us the two things we are looking for, evidence of Volufiline at the product level and third party manufacturing capability.
Therefore, for brands who are interested in Korean multi-active anti-ageing concepts, rather than a single ingredient name formula, Pion-Tech may be worth looking at.
As with several of the Korean companies here, I'd still like to know if the exact product shown publicly is available for private label adaptation, or if it just shows the manufacturer's formulation experience.
The difference is important.
A product doesn’t need to be on the market for another brand to copy outright to show that a lab knows how to work with an ingredient.
Finding a factory that has already worked with Volufiline is useful, but that should be the beginning of supplier evaluation rather than the end.
Volufiline™ is a branded cosmetic active associated with Anemarrhena asphodeloides.
When reviewing quotations, we would not assume that every supplier using the words “Volufiline,” “Anemarrhena extract” or “volume active” is talking about exactly the same commercial raw material.
Ask directly:
Those questions are particularly important when an ingredient becomes commercially popular and many similar product names begin appearing online.
Ingredient-led skincare often turns into a numbers competition.
Sometimes much larger percentages appear in marketing.
Those numbers mean very little until you know what is being measured.
Is the supplier talking about the percentage of the complete commercial ingredient?
A manufacturer should be able to explain that without avoiding the question.
From a product-development perspective, we would rather launch a stable, elegant and well-documented formula at an appropriate use level than choose a poor product simply because its front label displays the largest number.
Volufiline serum is currently the obvious product format, but it is far from the only possible commercial direction.
Depending on the target customer and brand positioning, we would consider products such as:
These products should not all use the same formulation approach.
An oil treatment has a completely different base system from an emulsion cream. Eye care has different sensorial and packaging requirements from body care. A lip product introduces another set of formulation and application considerations.
The best manufacturer therefore depends partly on what you are actually trying to build.
This is one area where brands should be conservative before artwork is finalized.
Croda currently positions Volufiline around the visible appearance of plumping and areas affected by volume loss.
That does not automatically mean a finished cosmetic can claim to permanently create facial fat, rebuild tissue, replace injectable fillers or medically restructure the face.
In the United States, FDA states that cosmetic claims must be truthful and not misleading. Claims that a product treats disease or affects the structure or function of the body can cause it to be regulated as a drug rather than simply a cosmetic.
The EU likewise applies common criteria for the justification of claims made in relation to cosmetic products under Commission Regulation (EU) No 655/2013.
For this reason, we prefer discussing the claim strategy before the packaging is printed.
Changing a sentence during formulation development is easy.
Changing 5,000 printed cartons is not.
A sample can tell you whether the serum spreads well, whether the cream feels sticky and whether you like the fragrance.
It cannot by itself demonstrate that a formula is ready for commercial manufacturing.
Depending on the product, manufacturing plan and destination market, a project may involve work such as:
FDA also makes clear that cosmetic companies are responsible for ensuring product safety, even though cosmetics do not generally go through FDA pre-market approval in the way drugs do.
When we evaluate another manufacturer's process, we therefore want to understand what happens between:
“sample approved”
and
“5,000 finished units shipped.”
If that part of the conversation remains vague, we would investigate before placing a production deposit.
There is no supplier in this list that is automatically the right choice for every buyer.
If I were launching a small US brand and wanted to test perhaps 25–100 private label units before committing serious inventory, Trilogy Laboratories would be one of the first companies I contacted. Its current private label structure makes that kind of low-risk validation unusually accessible.
If Made in France were central to the brand and I wanted custom formulation or a body/contour direction, Laboratoire Orescience would make more strategic sense.
For Korean derma or aesthetic positioning, I would compare LISSE KOREA, COSMEDIQUE and THE MOMENT. They each show a somewhat different approach: professional skincare at LISSE, established derma-focused manufacturing at COSMEDIQUE and more trend-forward multi-active concepts at THE MOMENT.
For a small serum-led test launch, Uniqueglobal is worth investigating.
For a broader set of formats, BORNTREE demonstrates experience working with Volufiline across several product types.
And when a brand comes to us looking for a customized series covering serum, serum oil, cream and eye care, that is the type of Volufiline development project we handle at Xiran Skincare.
The decision should ultimately come down to more than the lowest unit price.
We would compare:
formula quality + ingredient sourcing + MOQ + packaging + testing + documentation + communication + total landed cost.
That combination tells you much more about whether a factory fits your business than a polished factory video or an unusually cheap quotation.
Volufiline is having a strong commercial moment, and Croda's own 2026 commentary confirms renewed interest in the active.
That creates an opportunity for beauty brands, but it also makes supplier evaluation more important.
Once an ingredient becomes fashionable, the market quickly fills with similar product names, escalating percentage claims and suppliers trying to compete on speed or price.
We would not choose a manufacturer on that basis.
We would shortlist three to five suppliers, request samples and technical information, clarify the exact raw material being used and compare each proposal on formula, ingredient sourcing, testing, MOQ, packaging, documentation and total landed cost.
Volufiline may be the ingredient that gets a consumer to notice the product.
The formula, positioning and manufacturing partner are what determine whether the brand can build something sustainable after the trend brings them through the door.
If you are planning to develop a Volufiline serum, cream, eye treatment or a complete skincare range, our team at Xiran Skincare can help you evaluate the formula, packaging and production options for your market. Contact us to discuss your product idea and see which development route makes the most sense for your brand.
Yes. Several manufacturers currently offer existing Volufiline-containing formulas through private label, OEM or ODM programs.
You may be choosing an existing formula and adding your branding, adjusting an existing base formula, or developing a new formula around Volufiline. Those options normally have different MOQs, costs and timelines.
A comparison of current offerings reveals significant disparities in the MOQs specified by different providers. For instance, Trilogy currently offers production services with MOQs as low as 25 units per SKU, and Xiran Skincare’s private-label MOQs range from 500 to 1,000 units, whereas MOQs for some South Korean manufacturing solutions are considerably higher. MOQ requirements also vary depending on whether customization of packaging or formulations is involved.
Yes, and this may be one of the more interesting opportunities for brands entering the category later.
Publicly documented products already include face oils, creams, eye care, essence, lip care and body products. For a new brand, differentiation may come from choosing the right format rather than simply launching another Volufiline dropper serum.
We would start with seven questions:
Start by looking for manufacturers that can demonstrate real experience working with Volufiline rather than simply saying they can source trending ingredients.
We recommend asking for information about the Volufiline raw material, INCI, supplier documentation, available formulas, manufacturing standards, testing, MOQ and customization options. It is also useful to request samples before discussing bulk production.
For private label projects, confirm whether the manufacturer already has a production-ready Volufiline formula. For custom projects, ask whether its R&D team has experience incorporating the ingredient into the type of serum, cream, oil or eye product you want to develop.
